Revenue Breakdown
Composition ()
No data
Revenue Streams
Sensus Healthcare Inc (SRTS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product Revenue, accounting for 78.6% of total sales, equivalent to $5.75M. Another important revenue stream is Service Revenue. Understanding this composition is critical for investors evaluating how SRTS navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Sensus Healthcare Inc maintains a gross margin of 38.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -63.76%, while the net margin is -64.12%. These profitability ratios, combined with a Return on Equity (ROE) of -14.85%, provide a clear picture of how effectively SRTS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SRTS competes directly with industry leaders such as ARAY and LUNG. With a market capitalization of $67.67M, it holds a significant position in the sector. When comparing efficiency, SRTS's gross margin of 38.43% stands against ARAY's 23.19% and LUNG's 74.65%. Such benchmarking helps identify whether Sensus Healthcare Inc is trading at a premium or discount relative to its financial performance.
